# Avara Pharmaceutical Technologies, Inc., Norman, OK – FDA Inspections

Source: https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d

> Inspection records and compliance data for Avara Pharmaceutical Technologies, Inc. in Norman, Oklahoma. 5 FDA inspections on record, 1 Form 483, last inspected June 02, 2026.

---

## Details

- Name: Avara Pharmaceutical Technologies, Inc.
- FEI Number: 3004998655
- Address Line 1: 3300 Marshall Ave
- City: Norman
- State: Oklahoma
- Zip Code: 73072
- Country Name: United States
- Address: 3300 Marshall Ave, Norman, Oklahoma 73072, United States
- Country: United States

## Related Documents

- FDA Inspection 1322324 - Avara Pharmaceutical Technologies, Inc. - 2026-06-02 — source: FDA, date: June 2, 2026
- [FDA Inspection 1192124 - Avara Pharmaceutical Technologies, Inc. - 2022-10-31](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/a61728e1-15e0-451b-9b67-3ea6b39916a8) — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2022
- [FDA Inspection 1066751 - Avara Pharmaceutical Technologies, Inc. - 2018-09-26](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/29f4473c-c275-40ce-a917-6b0c5fbe4f4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2018
- FDA Inspection 773884 - Avara Pharmaceutical Technologies, Inc. - 2012-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2012
- [FDA Inspection 683863 - Avara Pharmaceutical Technologies, Inc. - 2010-09-27](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/bf254822-9bd4-489c-86c9-15d0e7a73028) — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2010

## Related Companies

- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [PharmaMax Pharmaceuticals, Ltd.](https://www.keypedia.com/companies/pharmamax-pharmaceuticals-ltd/36995055-289f-4dec-a34c-fe75a137e22b)
- [HIBROW HEALTHCARE PRIVATE LIMITED](https://www.keypedia.com/companies/hibrow-healthcare-private-limited/c5de7b11-f0fd-48a0-9bf9-e7730c9dc8fe)
- [Mylan Technologies, Inc.](https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70)
- [Braintree, A part of SEBELA Pharmaceuticals](https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2)
- [DPT Laboratories Ltd.](https://www.keypedia.com/companies/dpt-laboratories-ltd/3b2d6611-9567-4aa0-8e8c-25e1e0a1714e)
- [Lotus Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/lotus-pharmaceutical-co-ltd/1043820e-dbbd-403f-b81f-fc75b7ed8ab7)
- [Eisai Manufacturing Limited](https://www.keypedia.com/companies/eisai-manufacturing-limited/b46d49f1-76cf-4005-b60e-f75ff775f9f9)